SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Enthor in Therapeutics Announces License Agreement With Rumi Therapeutics

The companies announced a license agreement for ENT-7340, for fragile X syndrome.

SquawkNews Desk 1 updates Updated Oct 28, 2026, 12:33 PM UTC

Story updates

12:33:27 PM UTC
SquawkNews
Rumi to advance ENT-7340 as RTX-7340 for Fragile X syndrome and other neurological disorders ESCONDI

Related stories

Origin Energy Q1 APLNG Revenue Jumps on Higher Prices and Data Centre Demand M impact | EQUITY | Oct 30, 2026, 12:00 AM UTC Teck Resources Publishes Q3 2026 Earnings Call Transcript M impact | EQUITY | Oct 29, 2026, 11:59 PM UTC Aecon Group Reports Quarterly Results Through September 30 Aecon Group reported results for the quarter ended September 30. Figures are in Canadian dollars unless otherwise stated. M impact | EQUITY | Oct 29, 2026, 11:58 PM UTC Eastman Chemical Reports Quarterly Results Through September 30 The LSEG-generated earnings summary covers Eastman Chemical Co.'s quarter ended September 30. M impact | EQUITY | Oct 29, 2026, 11:58 PM UTC Coles Shares Fall 12% After Sales Disappoint, Fuel Costs Threaten Profits Coles said supermarket same-store sales rose 2.7% in the 13 weeks through Sept. 27 and warned that rising fuel costs would hurt profits. Its shares fell 12%, putting them on course M impact | EQUITY | Oct 29, 2026, 11:57 PM UTC TFS Financial Reports Quarterly Results TFS Financial Corp reported results for the quarter ended September 30. M impact | EQUITY | Oct 29, 2026, 11:56 PM UTC